[
  {
    "ts": null,
    "headline": "Is Bristol Myers Squibb (BMY) Stock Undervalued Right Now?",
    "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
    "url": "https://finnhub.io/api/news?id=bd6f964cab14068683cec196e257de88bcfeb70562b73271466c260d2e319c7e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735224010,
      "headline": "Is Bristol Myers Squibb (BMY) Stock Undervalued Right Now?",
      "id": 132165481,
      "image": "https://media.zenfs.com/en/zacks.com/3d7c5b2146ac04ffd51752e17ff2a619",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
      "url": "https://finnhub.io/api/news?id=bd6f964cab14068683cec196e257de88bcfeb70562b73271466c260d2e319c7e"
    }
  },
  {
    "ts": null,
    "headline": "PJP: Big Pharma Concentration Risks Amid Looming Confirmation Of RFK Jr.",
    "summary": "This article discusses the risk and opportunities of six major constituents of PJP ETF: Pfizer, Amgen, Gilead, AbbVie, BMY, and Merck. Read more here.",
    "url": "https://finnhub.io/api/news?id=d9924bfb15be4a412c5d30ffc3c153fb65db609d6f0526759c3ece67141e5e6e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735205436,
      "headline": "PJP: Big Pharma Concentration Risks Amid Looming Confirmation Of RFK Jr.",
      "id": 132164310,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/832255342/image_832255342.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "This article discusses the risk and opportunities of six major constituents of PJP ETF: Pfizer, Amgen, Gilead, AbbVie, BMY, and Merck. Read more here.",
      "url": "https://finnhub.io/api/news?id=d9924bfb15be4a412c5d30ffc3c153fb65db609d6f0526759c3ece67141e5e6e"
    }
  }
]